| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.09 | 0.07 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.042 | 0.4 |